Allelica to Provide Multi-ancestry Polygenic Risk Score to Baylor College of Medicine for Clinical Implementation
Allelica to Provide Multi-ancestry Polygenic Risk Score to Baylor College of Medicine for Clinical Implementation
In a presentation at the American Society of Human Genetics (ASHG) annual meeting last November, Allelica and Baylor shared results supporting the implementation of a comprehensive clinical workflow for PRS testing in multiple ancestries.NEW YORK, March 19, 2024 /PRNewswire/ -- Allelica, market leader in clinical solutions for polygenic risk score analysis and reporting, has announced a strategic collaboration with leading health sciences institution, Baylor College of Medicine (BCM), to integrate clinical, multi-ancestry polygenic risk score (PRS) testing into BCM's extensive patient services portfolio. This marks a significant milestone in making world class genomic medicine accessible, equitable, and impactful for patients across diverse communities.
紐約，2024年3月19日 /PRNewswire/ — 多基因風險評分分析和報告臨床解決方案的市場領導者Allelica宣佈與領先的健康科學機構貝勒醫學院（BCM）進行戰略合作，將臨床多祖先多基因風險評分（PRS）測試整合到BCM廣泛的患者服務組合中。這標誌着讓不同社區的患者能夠獲得、公平和有影響力的世界級基因組醫學方面的一個重要里程碑。
Allelica's PRS solution enables more precise identification of patients' genetic risk for coronary artery disease and other diseases and traits. The innovative testing method empowers physicians to tailor clinical management strategies, elevating the standard of patient care.
Allelica的PRS解決方案可以更精確地識別患者患冠狀動脈疾病和其他疾病和特徵的遺傳風險。這種創新的測試方法使醫生能夠量身定製臨床管理策略，從而提高患者護理的標準。
"Collaborating with Baylor is a tremendous step forward in making high-quality PRS testing accessible to individuals of all ancestral backgrounds," said Giordano Bottà, CEO and Co-founder of Allelica. "We are proud to work with Baylor towards our mission of accelerating the transition from sick care to healthcare."
Allelica首席執行官兼聯合創始人佐丹奴·博塔表示：“與貝勒合作是在讓所有祖先背景的人都能獲得高質量的PRS測試方面向前邁出的重要一步。”“我們很自豪能與貝勒合作，以實現我們的使命，即加快從疾病護理向醫療保健的過渡。”
In a presentation at the American Society of Human Genetics (ASHG) annual meeting last November, Allelica and Baylor shared results supporting the implementation of a comprehensive clinical workflow for PRS testing in multiple ancestries.
在去年11月的美國人類遺傳學會（ASHG）年會上的演講中，Allelica和Baylor分享了支持在多個祖先中實施PRS測試的全面臨床工作流程的成果。
"PRS are of high interest to our clinical partners. We've been working closely with Allelica to ensure a robust analytical framework that takes into account the diversity of our patient population," said Dr. Eric Venner, Associate Professor and Director of Clinical Informatics at the BCM Human Genome Sequencing Center.
“我們的臨床合作伙伴對PRS非常感興趣。我們一直在與Allelica密切合作，以確保建立一個考慮到我們患者群體的多樣性的強大分析框架。” BCM人類基因組測序中心副教授兼臨床信息學主任埃裏克·文納博士說。
Baylor is one of several institutions working with Allelica to provide clinical PRS testing to patients. Clinical PRS testing is quickly gaining traction across disease areas, including preventive cardiology and oncology, and across multiple health systems in the US and abroad, improving care for diverse patient populations at scale.
貝勒是與Allelica合作向患者提供臨床PRS測試的幾家機構之一。臨床PRS測試正在包括預防性心臟病學和腫瘤學在內的疾病領域以及美國和國外的多個衛生系統中迅速獲得關注，從而大規模改善了對不同患者群體的護理。
The BCM Human Genome Sequencing Center is employing Whole Genome Sequencing (WGS) technology together with Allelica's PREDICT software for PRS analysis and reporting. BCM is utilizing the on-premises version of Allelica's PREDICT software. PREDICT is available for laboratories as an in-lab solution or on the cloud and is compatible with WGS data and genome-wide microarray.
BCM人類基因組測序中心正在使用全基因組測序（WGS）技術以及Allelica的PREDICT軟件進行PRS分析和報告。BCM 正在使用 Allelica 的 PREDICT 軟件的本地版本。PREDICT 可作爲實驗室內解決方案或雲端提供給實驗室，並且與 WGS 數據和全基因組微陣列兼容。
A key aspect of Allelica and BCM's joint efforts is the focus on closing the equity gap in genomic medicine. By making PRS testing available to individuals of all ancestries through the use of multi-ancestry PRSs, Allelica aims to ensure that diverse populations benefit equally from the latest advancements in genomic testing.
Allelica和BCM共同努力的一個關鍵方面是將重點放在縮小基因組醫學的公平差距上。通過使用多祖先的PRS向所有祖先的個人提供PRS測試，Allelica旨在確保不同人群平等地受益於基因組測試的最新進展。
About Allelica
Allelica is a leading genomic software company that specializes in secure and scalable solutions to implement clinical bioinformatics solutions. Through the incorporation of genetics into disease risk assessments, Allelica is helping to build the foundations of preventive genomics medicine. To learn more, visit allelica.com.
關於 Allelica
Allelica是一家領先的基因組軟件公司，專門提供安全和可擴展的解決方案，以實施臨床生物信息學解決方案。通過將遺傳學納入疾病風險評估，Allelica正在幫助建立預防性基因組學醫學的基礎。要了解更多信息，請訪問allelica.com。
SOURCE Allelica, Inc.
來源 Allelica, Inc.
譯文內容由第三人軟體翻譯。
